Daniel J. Burge
Keine laufenden Positionen mehr
Karriereverlauf von Daniel J. Burge
Ehemalige bekannte Positionen von Daniel J. Burge
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2004 | 29.08.2008 |
AMGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2002 | 01.01.2003 |
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2000 | 01.01.2002 |
DERMIRA, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
FORTE BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Daniel J. Burge
Thomas Jefferson University | Doctorate Degree |
Taylor University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
Chief Tech/Sci/R&D Officer | 5 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
AMGEN INC. | Health Technology |
FORTE BIOSCIENCES, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Health Technology |
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
Dermira, Inc.
Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
- Börse
- Insiders
- Daniel J. Burge
- Erfahrung